Insiders Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2026 BST			5-day change	1st Jan Change
3.580 ^USD	-1.10%		-16.55%	-41.79%

05-06	Myriad Genetics, Inc., Q1 2026 Earnings Call, May 05, 2026
05-05	Myriad Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2026	CI

Insiders

02-27	Myriad Genetics Insider Bought Shares Worth $494,722, According to a Recent SEC Filing	MT
03/10/25	Myriad Genetics, Inc. Announces Executive Changes, Effective October 24, 2025	CI
18/08/25	Myriad Genetics appoints Ben Wheeler chief financial officer	RE
18/08/25	Myriad Genetics Names Ben Wheeler CFO	MT
07/04/25	Myriad Genetics, Inc. Appoints Brian Donnelly as Chief Commercial Officer, Effective May 1, 2025	CI
25/02/25	Myriad Genetics Appoints Sam Raha as Chief Executive	MT
24/02/25	Myriad Genetics Appoints Sam Raha As President And CEO	RE
24/02/25	Myriad Genetics, Inc. Announces Chief Executive Officer Changes	CI
24/02/25	Myriad Genetics, Inc. Announces Management Changes	CI
10/12/24	Myriad Genetics Elects Mark S. Davis as New Board Member	CI
12/09/24	Myriad Genetics Insider Sold Shares Worth $400,800, According to a Recent SEC Filing	MT
09/09/24	Myriad Genetics Insider Sold Shares Worth $270,520, According to a Recent SEC Filing	MT
05/09/24	Myriad Genetics Insider Sold Shares Worth $1,285,851, According to a Recent SEC Filing	MT
31/07/24	Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer, Effective September 3, 2024	CI
31/01/24	Myriad Genetics Names George Daneker Jr. as President, Chief Clinical Officer of Oncology	MT
30/01/24	Myriad Genetics, Inc. Appoints George Daneker as President and Chief Clinical Officer of Oncology, Effective March 18, 2024	CI
21/12/23	Myriad Genetics Names Scott Leffler as Chief Financial Officer, Reiterates Outlook	MT
03/11/23	Myriad Genetics Insider Sold Shares Worth $470,622, According to a Recent SEC Filing	MT
01/11/23	Myriad Genetics Names Sam Raha as Chief Operating Officer	MT
01/11/23	Myriad Genetics, Inc. Appoints Samraat S. Raha as Chief Operating Officer, Effective as of December 11, 2023	CI
05/10/23	Myriad Genetics COO Nicole Lambert to Step Down	MT
05/10/23	Myriad Genetics, Inc. Announces Executive Changes	CI
05/06/23	Insider Sell: Myriad Genetics	MT
31/05/23	Myriad Genetics, Inc. Appoints Adam Brufsky as Scientific Advisor	CI
28/03/23	Insider Sell: Myriad Genetics	MT